David J. Perry
Impact in
- Internal Medicine top 0.2%
- Venous Thromboembolism Diagnosis and Management
- Hematology top 0.2%
- Blood Coagulation and Thrombosis Mechanisms
- Hemophilia Treatment and Research
- Platelet Disorders and Treatments
Papers in
- Hematology 70
- Blood Coagulation and Thrombosis Mechanisms 42
- Hemophilia Treatment and Research 38
- Platelet Disorders and Treatments 18
-
- Venous Thromboembolism Diagnosis and Management 17
- Co-authors
- Robert C. TaitNina SaloojaDavid KeelingRobin W. CarrellTrevor BaglinSteve KitchenHenry G. WatsonMichael Laffan
- Journals
- British Journal of Haematology (13 papers)Blood Coagulation & Fibrinolysis (11 papers)Haemophilia (10 papers)Thrombosis and Haemostasis (10 papers)Cancer (6 papers)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
David J. Perry
183 papers receiving 6.9k citations
Hit Papers
Peers
Comparison fields: 5 of 174
- Internal Medicine 1.3k
- Hematology 3.2k
- Critical Care and Intensive Care Medicine 429
- Genetics 809
- Cardiology and Cardiovascular Medicine 1.1k
Countries citing papers authored by David J. Perry
This map shows the geographic impact of David J. Perry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Perry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Perry more than expected).
Fields of papers citing papers by David J. Perry
This network shows the impact of papers produced by David J. Perry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Perry. The network helps show where David J. Perry may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David J. Perry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2016 | 29 | |
| 3 | 2011 | 24 | |
| 4 | 2009 | 26 | |
| 5 | 2009 | 20 | |
| 6 | 2007 | 67 | |
| 7 | 2006 | 9 | |
| 8 | 2003 | 1 | |
| 9 | 2003 | 1 | |
| 10 | 2003 | 69 | |
| 11 | 2002 | 54 | |
| 12 | 2001 | 20 | |
| 13 | 2000 | 16 | |
| 14 | Novel cationic lipidic peptide dendrimer vectors in vitro gene delivery | 1999 | 25 |
| 15 | 1999 | 28 | |
| 16 | 1996 | 40 | |
| 17 | 1991 | 44 | |
| 18 | 1990 | 11 | |
| 19 | 1989 | 53 | |
| 20 | Dose Modification for PDQ. | 1987 | 1 |
About David J. Perry
David J. Perry is a scholar working on Hematology, Internal Medicine, Genetics, Otorhinolaryngology and Critical Care and Intensive Care Medicine, having authored 187 papers that have together received 7.1k indexed citations. Recurring topics across this work include Blood Coagulation and Thrombosis Mechanisms (42 papers), Hemophilia Treatment and Research (38 papers), Platelet Disorders and Treatments (18 papers), Venous Thromboembolism Diagnosis and Management (17 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (14 papers), Cancer-related gene regulation (12 papers), Atrial Fibrillation Management and Outcomes (7 papers) and Peptidase Inhibition and Analysis (7 papers). The work is most often cited by research in Internal Medicine (1.3k citations), Hematology (3.2k citations), Critical Care and Intensive Care Medicine (429 citations), Genetics (809 citations) and Cardiology and Cardiovascular Medicine (1.1k citations). David J. Perry has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Robert C. Tait, Nina Salooja, David Keeling, Robin W. Carrell, Trevor Baglin, Steve Kitchen, Henry G. Watson, Michael Laffan, Michael Makris and John Pasi. Their work appears in journals such as British Journal of Haematology, Blood Coagulation & Fibrinolysis, Haemophilia, Thrombosis and Haemostasis and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.